High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Moussiliou, Azizath ^a,b,c   De Tove, Yolande Sissinto Savi ^c   Doritchamou, Justin ^a,b,c   Luty, Adrian J F ^a,b   Massougbodji, Achille ^c   Alifrangis, Michael ^d,e   Deloron, Philippe ^a,b   Ndam, Nicaise Tuikue ^a,b,c  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF ABOMEY CALAVI   (Benin)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e University of Copenhagen   (Denmark)

Author keywords

Benin; IPTp; Mutations; pfdhfr; pfdhps; Plasmodium falciparum; Pregnancy; Sulphadoxine pyrimethamine

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PROTOZOAL PROTEIN; PYRIMETHAMINE; SULFADOXINE;

ADULT; ANEMIA; ARTICLE; BENIN; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITE CLEARANCE; PARASITEMIA; PLASMODIUM FALCIPARUM; POINT MUTATION; PREGNANCY; PREGNANT WOMAN; PREVALENCE; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; ADOLESCENT; DRUG COMBINATION; DRUG EFFECTS; GENETICS; HAPLOTYPE; MALARIA, FALCIPARUM; PARASITOLOGY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIMALARIALS; BENIN; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; FEMALE; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROSPECTIVE STUDIES; PROTOZOAN PROTEINS; PYRIMETHAMINE; RECURRENCE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE; YOUNG ADULT;

EID: 84878745472     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-195     Document Type: Article

References (43)

1. An analysis of malaria in pregnancy in Africa. Brabin BJ, Bull World Health Organ 1983 61 1005 1016 6370484
2. Adherence of Plasmodium falciparum to chondroitin sulfate a in the human placenta. Fried M, Duffy PE, Science 1996 272 1502 1504 10.1126/science.272. 5267.1502 8633247
3. Epidemiology and burden of malaria in pregnancy. Desai M, TerKuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD, Lancet Infect Dis 2007 7 93 104 10.1016/S1473-3099(07)70021-X 17251080
4. Proxies and prevention of malaria in pregnancy. McGready R, Nosten F, Lancet Infect Dis 2012 12 902 903 10.1016/S1473-3099(12)70240-2 22995851
5. WHO, A strategic framework for malaria prevention and control during pregnancy in the Africa region Brazzaville, Congo: WHO Regional Office for Africa 2004 AFR/MAL/04/01
6. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Watkins WM, Mberu EK, Winstanley PA, Plowe CV, Parasitol Today 1997 13 459 464 10.1016/S0169-4758(97)01124-1 15275132
7. More on 'the efficacy of antifolate antimalarial combinations in Africa'. Watkins WM, Mberu EK, Winstanley PA, Plowe CV, Parasitol Today 1999 15 131 132 10.1016/S0169-4758(99)01419-2 10322331
8. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Peterson DS, Walliker D, Wellems TE, Proc Natl Acad Sci U S A 1988 85 9114 9118 10.1073/pnas.85.23.9114 2904149
9. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Triglia T, Menting JGT, Wilson C, Cowman AF, Proc Natl Acad Sci U S A 1997 94 13944 13949 10.1073/pnas.94.25. 13944 9391132
10. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Cortese JF, Plowe CV, Mol Biochem Parasitol 1998 94 205 214 10.1016/S0166-6851(98)00075-9 9747971
11. Mechanisms of resistance of malaria parasites to antifolates. Gregson A, Plowe CV, Pharmacol Rev 2005 57 117 145 10.1124/pr.57.1.4 15734729
12. P. falciparum dihydrofolate reductase and dihydropteroatesynthase mutations: epidemiology and role in clinical resistance to antifolates. Plowe CV, Kublin JG, Doumbo OK, Drug Resist Updat 1998 1 389 396 10.1016/S1368- 7646(98)80014-9 17092820
13. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, J Infect Dis 2002 185 380 388 10.1086/338566 11807721
14. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G, AmJTrop Med Hyg 2003 69 247 252
15. Can pretreatment screening for dhps and dhfr point mutations in Plasmodium falciparum infections be used to predict sulfadoxine-pyrimethamine treatment failure? Omar SA, Adagu IS, Warhurst DC, Trans R Soc Trop Med Hyg 2001 95 315 319 10.1016/S0035-9203(01)90250-0 11491006
16. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE, Clin Infect Dis 2011 53 224 230 10.1093/cid/cir376 21765070
17. Infections with Plasmodium falciparum sextuple Pfdhfr/Pfdhps allelic haplotypes during pregnancy is associated with decreased birth weight in Korogwe, Tanzania. Daniel TR M, Schmiegelow C, Mmbando B, Boström S, Oesterholt M, Magistrado P, Perhson C, John D, Salanti A, Luty AJF, Lemnge M, Theander T, Alifrangis M, Lusingu J, Emer Inf Dis In press
18. Drug resistance maps: http://www.drugresistancemaps.org
19. Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast. Nahum A, Erhart A, Ahounou D, Bonou D, Van Overmeir C, Menten J, Akogbeto M, Coosemans M, Massougbodji A, D'Alessandro U, West Africa. Malar J 2009 8 37
20. The use of intermittent preventive treatment with sulfadoxine- pyrimethamine for preventing malaria in pregnant women. Leke RG, Taylor DW, Clin Infect Dis 2011 53 231 233 10.1093/cid/cir383 21765071
21. World Health Organization, Evidence Review Group: Intermittent Preventive Treatment of malaria in pregnancy (IPTp) with Sulfadoxine- Pyrimethamine (SP) Geneva: WHO 2012 http://www.who.int/malaria/mpac/sep2012/iptp-sp-erg-meeting- report-july2012.pdf
22. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin. Bertin G, Briand V, Bonaventure D, Carrieu A, Massougbodji A, Cot M, Deloron P, Malar J 2011 10 196 10.1186/1475-2875-10-196 21767415
23. The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Kelly-Hope LA, McKenzie FE, Malar J 2009 8 19 10.1186/1475-2875-8-19 19166589
24. A multiplex real-time PCR assay for Plasmodium parasites pan-species and species-specific detection and quantification in malaria vectors. Sandeu M, Moussiliou A, Moiroux N, Padonou G, Massougbodji A, Corbel V, Ndam NT, PLoS One 2012 7 52719 10.1371/journal.pone.0052719 23285168
25. Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin. Huynh BT, Fievet N, Gbaguidi G, Dechavanne S, Borgella S, Guézo-Mévo B, Massougbodji A, Ndam NT, Deloron P, Cot M, AmJTrop Med Hyg 2011 85 214 220 10.4269/ajtmh.2011.11-0103
26. PCR and strain identification in plasmodium falciparum. Wooden J, Kyes S, Sibley CH, Parasitol Today 1993 9 303 305 10.1016/0169-4758(93)90131-X 15463789
27. Asymptomatic carriage of Plasmodium in urban Dakar: the risk of malaria should not be underestimated. Diallo A, Ndam NT, Moussiliou A, Dos Santos S, Ndonky A, Borderon M, Oliveau S, Lalou R, Le Hesran JY, PLoS One 2012 7 31100 10.1371/journal.pone.0031100 22363558
28. Molecular determination of point mutation haplotypes in the dihydrofolatereductase and dihydropteroatesynthase of Plasmodium falciparum in three districts of northern Tanzania. Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C, Antimicrob Agents Chemother 2003 47 1347 1354 10.1128/AAC.47.4.1347-1354.2003 12654669
29. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolatereductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology. Alifrangis M, Enosse S, Pearce R, Drakeley C, Roper C, Khalil IF, Nkya WM, Rønn AM, Theander TG, Bygbjerg IC, AmJTrop Med Hyg 2005 72 155 162
30. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S, Trans R Soc Trop Med Hyg 1999 93 369 734 10.1016/S0035-9203(99)90120-7 10674079
31. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. Maïga O, Djimdé AA, Hubert V, Renard E, Aubouy A, Kironde F, Nsimba B, Koram K, Doumbo OK, Le Bras J, Clain J, J Infect Dis 2007 196 165 172 10.1086/518512 17538897
32. Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Sridaran S, McClintock SK, Syphard LM, Herman KM, Barnwell JW, Udhayakumar V, Malar J 2010 9 247 10.1186/1475-2875-9-247 20799995
33. Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine- pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso. Somé AF, Séré YY, Dokomajilar C, Zongo I, Rouamba N, Greenhouse B, Ouédraogo JB, Rosenthal PJ, Antimicrob Agents Chemother 2010 54 1949 1954 10.1128/AAC.01413-09 20231394
34. Selective sweeps and genetic lineages of Plasmodium falciparum drug-resistant alleles in Ghana. Alam MT, De Souza DK, Vinayak S, Griffing SM, Poe AC, Duah NO, Ghansah A, Asamoa K, Slutsker L, Wilson MD, Barnwell JW, Udhayakumar V, Koram KA, J Infect Dis 2011 203 220 227 10.1093/infdis/jiq038 21288822
35. Molecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania. Malisa A, Pearce R, Abdullah S, Mutayoba B, Mshinda H, Kachur P, Bloland P, Roper C, Afr Health Sci 2011 11 142 150 21857842
36. Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana. Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, Koram KA, AmJTrop Med Hyg 2012 87 996 1003 10.4269/ajtmh.2012.12-0202
37. Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria. Lin JT, Mbewe B, Taylor SM, Luntamo M, Meshnick SR, Ashorn P, Trop Med Int Health 2013 18 175 178 10.1111/tmi.12028 23198734
38. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Iriemenam NC, Shah M, Gatei W, Van Eijk AM, Ayisi J, Kariuki S, Vanden Eng J, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP, Malar J 2012 11 134 10.1186/1475-2875-11-134 22540158
39. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. Faucher JF, Aubouy A, Adeothy A, Cottrell G, Doritchamou J, Gourmel B, Houzé P, Kossou H, Amedome H, Massougbodji A, Cot M, Deloron P, J Infect Dis 2009 200 57 65 10.1086/599378 19469703
40. Randomized trial of artesunate + amodiaquine, sulfadoxine-pyrimethamine + amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania. Mutabingwa TK, Muze K, Ord R, Briceño M, Greenwood BM, Drakeley C, Whitty CJ, PLoS One 2009 4 5138 10.1371/journal.pone.0005138 19352498
41. Sulphadoxine/ pyrimethamine intermittent preventive treatment for malaria during pregnancy. Deloron P, Bertin G, Briand V, Massougbodji A, Cot M, Emerg Infect Dis 2010 16 1666 1670 10.3201/eid1611.101064 21029522
42. Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration. Huynh BT, Fievet N, Briand V, Borgella S, Massougbodji A, Deloron P, Cot M, PLoS One 2012 7 35342 10.1371/journal.pone.0035342 22514730
43. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. Kayentao K, Garner P, Van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, Ter Kuile FO, JAMA 2013 309 594 604 10.1001/jama.2012.216231 23403684